Global Blood Collection Devices Market Expected to Grow at a Decent CAGR of 7% from 2021 to 2026 – Rising Adoption of Liquid Biopsy Tests
Medi-Tech Insights: The increase in cases of trauma and accidents, the increase in surgical procedures worldwide, the rapid growth of infectious diseases, government initiatives for blood donations and the adoption of biopsy tests liquid are some of the key factors driving the global blood collection devices market.
BRUSSELS, BELGIUM, Aug. 02, 2022 (GLOBE NEWSWIRE) —
Blood collection or blood sampling can be done in different ways, such as arterial sampling, venipuncture, and finger sampling. Blood samples and other biological samples must be collected in order to fully understand, prevent and cure disease. In addition, blood is also collected from the donor through a blood donation process which is then separated into different blood components as required during transfusion procedures.
New Pproduct Ddevelopments Booster Aoption of Blood Collection Devices Market
The continuous development of blood collection devices has resulted in the development of efficient products with artificial intelligence (AI), ultrasound-guided 3D reconstruction, ease of use at home and safe large volume blood collection, among others. Some of the new product developments are listed below:
In May 2022, speed bump launched its advanced self-contained venipuncture blood collection device that combines artificial intelligence (AI) with robotic needle insertion and ultrasound-guided 3D reconstruction, ensuring safe and accurate blood collection.
In May 2022, Labcorp launched a home collection device from Weavr Health, a diagnostics company, through Labcorp OnDemand that measures HbA1c from a small blood sample for diabetes risk testing.
In April 2022, Owen Mumford Ltd. launched a portfolio of three venous blood collection devices under its Unistik brand. These three devices, namely Unistik ShieldLock, Unistik ShieldLock Ultra and Unistik VacuFlip are designed to collect large volumes of blood safely, minimizing the risk of needlestick injury (NSI).
In February 2022, Track launched RNA Complete BCT, a new blood collection tube that maintains cell-free RNA concentration for up to seven days when stored at room temperature, providing a convenient method for sample collection, storage and transport.
Investments and VSollaborations to feed Blood Collection Devices Market grow
Market players operating in the blood collection devices market are constantly focusing on investments and collaborations to advance new blood collection technologies. Such advancements tend to provide a competitive edge to manufacturers. Some of the recent developments are listed below-
In May 2022, Becton, Dickinson and company extended its collaboration with Babson Diagnostics to continue the research and development of blood collection devices that are less invasive, more convenient and enable self-sampling.
In December 2021, Cup secured $100 million in funding to scale up production and commercialization of its simplified “on-demand” blood collection devices. Tasso’s OnDemand devices draw blood from the skin through capillaries using a push button attached to the upper arm.
In May 2019, Velano Vascular secured a $10 million investment from Intermountain Healthcare to fuel the commercialization of its vascular access solutions, including a needle-free blood collection device.
Competitive landscape analysis: Blood Collection Devices Market
The global blood collection devices market is marked by the presence of key market players such as Becton, Dickinson and Company (USA); Terumo BCT (USA); Haemonetics Corporation (USA); Grifols, SA (Spain); Fresenius Kabi AG (Germany); and others.
Explore In-Depth Insights of Blood Collection Devices Market @ https://meditechinsights.com/blood-collection-devices-market/
About Medi-Tech Knowledge:
Medi-Tech Insights is a business research and analytics company focused on healthcare. Our clients include Fortune 500 companies, blue chip investors and hyper-growth start-ups. We have successfully completed more than 100 projects in digital health, health informatics, medical technology, medical devices and pharmaceutical services.
Partner, Medi-Tech Insights
+32 498 86 80 79